Aprameya Engineering share price
NSE: APRAMEYAHealthcare Equipment & Supplies
Aprameya Engineering Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 2024 · Issue price ₹58
Last close ₹96.00up ₹1.30 (1.37%)
Share price at the NSE close on 28 Oct 2026. Previous close ₹94.70.
28 Oct: open ₹96.40, high ₹96.95, low ₹93.05
52-week range of traded prices to 28 Oct 2026
₹75.00Low, 21 Oct 2026₹360.00High, 21 Nov 2025
- Next results date: the board meets on 14 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹183 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 35.83
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.63
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it, the company's own balance sheet from before it began consolidating; the two agree where both are first on record.
- 7.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 13.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.10
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 4,50066.7% delivered
Results
Standalone, as consolidated accounts are on record for only 1 of the last ten years; ₹ crore.Aprameya Engineering half-yearly results
Half year to Mar 2026, against the half year before
- RevenueRevenue. The pill is the change in revenue against the half year before: this period's figure divided by that one's, less one, in per cent.
- ₹13 Crdown 70.08%
- Net profitNet profit. Under it, net profit in the half year before. A change in per cent is not worked out where either period is a loss or nothing. Net profit in the glossary
- −₹1.72 CrHalf year to Sep 2025: ₹6.76 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- −13.6%
Revenue by half year
Peak revenue ₹126 Cr, half year to Mar 2025; lowest ₹9.27 Cr, half year to Sep 2024
Net profit by half year, a loss in red
- Net profit
- Loss
A loss in the half year to Mar 2026, −₹1.72 CrA loss in 2 of the 4 half years shown
| ₹ crore | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue | 9 | 126 | 42 | 13 |
| Net profit | −2 | 18 | 7 | −2 |
| Net margin | −18.6% | 14.1% | 16.0% | −13.6% |
Standalone. The 4 half years from Sep 2024, the first on record. The latest is shaded.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹55 Crdown 59.66%
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹5.04 Crdown 68.72%
- Net margin
- 9.2%
Revenue by year
Peak revenue ₹136 Cr, year to Mar 2025; lowest ₹55 Cr, year to Mar 2026
Net profit by year, a loss in red
| ₹ crore | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue | 136 | 55 |
| Net profit | 16 | 5 |
| Net margin | 11.9% | 9.2% |
Standalone. Years to March. The latest is shaded.
Business segments
Share of revenue, year to Mar 2026, consolidated.Segment revenue and profit
- Turnkey project supplyTurnkey project supply, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹44.5 Cr80.8%
- Trading SalesTrading Sales, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹10.6 Cr19.2%
Valuation
Today, against the company's own history. Dividend yield is not shown: no dividend in the years on record.Aprameya Engineering PE ratio and valuation
Price to earnings
At or below today's level on 62% of 244 trading days over the last year.
LowestHighest
Its median25.37Industry median21.89
Price to book
At or below today's level on 4% of 244 trading days over the last year.
LowestHighest
Its median5.69Industry median2.55
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +98.9% | −68.7% | +535.8% | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth over 1 year is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.
Promoter and insider buying and selling
Trades made since 29 Oct 2025.Aprameya Engineering insider trading
Bought on the marketBought on the market. The value each filer stated for its purchases on the exchange, added up; gifts, transfers and pledges are not counted. A purchase filed with no value is counted under the sum, not in it. Sold on the marketSold on the market. The value each filer stated for its sales on the exchange, added up; gifts, transfers and pledges are not counted. A sale filed with no value is counted under the sum, not in it.
- Directors and key managers6 purchases, 0 sales₹2.35 CrNo saleNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.₹2.35 Cr
- Promoters and promoter group: no market trade
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Aprameya Engineering competitors and peers
Medical Equipment & Supplies, 27 listed companies, priced on 28 Oct 2026. The table lists the 8 companies closest to Aprameya Engineering in market cap. 1 company in the table last traded before then: its row is priced on its last trade.Healthcare companies
Where the company sits among the companies nearest its size
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Fabtech TechnologiesFABTECH | 556 | 15.62 | 1.27 | – | – | 11.2% | 4.2% | 0.48% |
 Prevest DenproPREVEST | 456 | 20.98 | 3.65 | – | – | 18.9% | – | 0.26% |
 QMS Medical Allied ServicesQMSMEDI | 344 | – | 3.30 | – | – | – | – | 0.28% |
 NurecaNURECA | 287 | 60.23 | 1.53 | +33.7% | +15.9% | 2.5% | 2.0% | 0.00% |
 EarkartEARKART | 164 | 33.16 | 2.55 | – | – | 7.7% | 12.0% | 0.00% |
| Avience BiomedicalsAVIENCE | 148 | 16.96 | – | – | – | 27.9% | – | 0.00% |
 Vaidya Sane Ayurved LaboratoriesMADHAVBAUG | 147 | 16.38 | 2.05 | +19.0% | +34.9% | 13.4% | – | 0.00% |
 Choksi AsiaCHOKSI | 123 | 23.62 | 2.91 | +21.4% | – | 13.1% | 14.7% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Aprameya Engineering announcements
Oct 2026
Aug 2026
Jul 2026
Jun 2026
25 Jun · Business
Aprameya Engineering share price by year
Each calendar year to 2025.Aprameya Engineering share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 315.55 | +201.2% | 352.75 | 90.25 |
| 2024 | 104.75 | – | 120.25 | 56.00 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2024 is from its first session, 1 Aug 2024.
Recent sessions
The 9 trading days to 27 Oct 2026, as traded on NSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 27 Oct 2026 | 93.65 | 98.00 | 90.00 | 94.70 | 93.22 | 14,500 | 51.7% |
| 26 Oct 2026 | 95.90 | 95.90 | 86.00 | 90.00 | 89.61 | 10,000 | 60.0% |
| 23 Oct 2026 | 91.80 | 91.80 | 85.00 | 89.90 | 87.63 | 5,500 | 72.7% |
| 22 Oct 2026 | 80.00 | 91.80 | 79.00 | 87.15 | 86.75 | 27,500 | 50.9% |
| 21 Oct 2026 | 86.50 | 86.50 | 75.00 | 79.60 | 79.91 | 26,500 | 77.4% |
| 19 Oct 2026 | 87.00 | 87.00 | 85.00 | 86.50 | 86.17 | 4,500 | 88.9% |
| 16 Oct 2026 | 92.95 | 92.95 | 84.00 | 88.30 | 87.67 | 30,500 | 82.0% |
| 15 Oct 2026 | 100.50 | 100.50 | 89.95 | 91.30 | 93.45 | 21,500 | 79.1% |
| 14 Oct 2026 | 97.75 | 101.50 | 95.00 | 98.00 | 97.58 | 22,000 | 84.1% |
Prices in ₹ per share as traded, not adjusted.
Company details
- NSE symbol
- APRAMEYA
- ISIN
- INE0LQG01010
- Industry
- Healthcare Equipment & Supplies